Company / Income Tax per Share
Regeneron Pharmaceuticals Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$6.38
FY2025
5-year range
$2.19 / $6.38
FY2021-FY2025
Trend
+97.3%
vs FY2024
Sector context
#3 of 201
Health Care
What the data says
Among 201 Health Care companies, Regeneron Pharmaceuticals is in the bottom 1% for income tax per share. Income Tax per Share has fluctuated over the past 10 years, ranging from $0.94 in FY2018 to $7.64 in FY2017.
Based on SEC 10-K filings.
6.38 in FY2025 with a 5-year CAGR of +46.4%. Ranks 3rd among 201 companies in Health Care.
Increased from $2.19 to $6.38 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +35.2%
- 5-Year CAGR
- +46.4%
- 10-Year CAGR
- -
Sector benchmark
+373.5% above sector average
Key checks
Key Insights
- In FY2025, income tax per share increased 97.3% year-over-year.
- Ranks #3 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2017.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.03 (safe zone, above 2.9 threshold)
- Strong profit margin: 32.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.38 | +97.3% |
| FY2024 | $3.24 | +47.8% |
| FY2023 | $2.19 | -15.2% |
| FY2022 | $2.58 | -5.6% |
| FY2021 | $2.73 | +187.7% |
| FY2020 | $0.95 | -64.8% |
| FY2019 | $2.70 | +188.2% |
| FY2018 | $0.94 | -87.7% |
| FY2017 | $7.64 | +99.4% |
| FY2016 | $3.83 | -27.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026